Tubacex Future Growth
Future criteria checks 4/6
Tubacex is forecast to grow earnings and revenue by 23.3% and 8.5% per annum respectively. EPS is expected to grow by 21.2% per annum. Return on equity is forecast to be 19.2% in 3 years.
Key information
23.3%
Earnings growth rate
21.2%
EPS growth rate
| Metals and Mining earnings growth | 14.0% |
| Revenue growth rate | 8.5% |
| Future return on equity | 19.2% |
| Analyst coverage | Low |
| Last updated | 17 Apr 2024 |
Recent future growth updates
Recent updates
Is Tubacex (BME:TUB) A Risky Investment?
Apr 05
Is Tubacex (BME:TUB) Using Too Much Debt?
Aug 13Is There An Opportunity With Tubacex, S.A.'s (BME:TUB) 43% Undervaluation?
Jul 06Is Tubacex (BME:TUB) A Risky Investment?
Sep 30Tubacex, S.A. (BME:TUB) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Jul 31Time To Worry? Analysts Are Downgrading Their Tubacex, S.A. (BME:TUB) Outlook
Jul 29Does Tubacex (BME:TUB) Have A Healthy Balance Sheet?
May 14What Is The Ownership Structure Like For Tubacex, S.A. (BME:TUB)?
Mar 15Reflecting on Tubacex's (BME:TUB) Share Price Returns Over The Last Three Years
Feb 07
Is Tubacex (BME:TUB) Using Debt In A Risky Way?
Dec 14A Rising Share Price Has Us Looking Closely At Tubacex, S.A.'s (BME:TUB) P/E Ratio
Jun 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,122 | 76 | 56 | 125 | 3 |
| 12/31/2025 | 1,093 | 69 | 32 | 132 | 4 |
| 12/31/2024 | 993 | 54 | 67 | 134 | 1 |
| 12/31/2023 | 854 | 36 | 28 | 91 | N/A |
| 9/30/2023 | 832 | 31 | N/A | N/A | N/A |
| 6/30/2023 | 799 | 31 | 66 | 99 | N/A |
| 3/31/2023 | 792 | 27 | N/A | N/A | N/A |
| 12/31/2022 | 717 | 20 | 61 | 88 | N/A |
| 9/30/2022 | 624 | 13 | N/A | N/A | N/A |
| 6/30/2022 | 550 | -2 | 14 | 46 | N/A |
| 3/31/2022 | 415 | -16 | N/A | N/A | N/A |
| 12/31/2021 | 344 | -36 | -51 | -24 | N/A |
| 9/30/2021 | 339 | -45 | N/A | N/A | N/A |
| 6/30/2021 | 327 | -43 | -37 | -18 | N/A |
| 3/31/2021 | 415 | -40 | N/A | N/A | N/A |
| 12/31/2020 | 463 | -27 | -33 | -9 | N/A |
| 9/30/2020 | 532 | -9 | N/A | N/A | N/A |
| 6/30/2020 | 577 | -2 | -43 | 16 | N/A |
| 3/31/2020 | 629 | 8 | N/A | N/A | N/A |
| 12/31/2019 | 618 | 11 | 20 | 84 | N/A |
| 9/30/2019 | 637 | 12 | N/A | N/A | N/A |
| 6/30/2019 | 590 | 16 | -42 | -6 | N/A |
| 3/31/2019 | 656 | 17 | N/A | N/A | N/A |
| 12/31/2018 | 626 | 17 | -45 | -16 | N/A |
| 9/30/2018 | 644 | -8 | N/A | N/A | N/A |
| 6/30/2018 | 613 | -15 | 16 | 49 | N/A |
| 3/31/2018 | 532 | -20 | N/A | N/A | N/A |
| 12/31/2017 | 495 | -20 | -34 | 2 | N/A |
| 9/30/2017 | 488 | 0 | N/A | N/A | N/A |
| 6/30/2017 | 479 | 1 | N/A | -2 | N/A |
| 3/31/2017 | 509 | 4 | N/A | N/A | N/A |
| 12/31/2016 | 499 | 1 | N/A | 50 | N/A |
| 9/30/2016 | 504 | -5 | N/A | N/A | N/A |
| 6/30/2016 | 497 | -4 | N/A | 35 | N/A |
| 3/31/2016 | 499 | 1 | N/A | N/A | N/A |
| 12/31/2015 | 537 | 8 | N/A | 62 | N/A |
| 9/30/2015 | 564 | 19 | N/A | N/A | N/A |
| 6/30/2015 | 577 | 24 | N/A | 93 | N/A |
| 3/31/2015 | 569 | 25 | N/A | N/A | N/A |
| 12/31/2014 | 549 | 24 | N/A | 70 | N/A |
| 9/30/2014 | 545 | 22 | N/A | N/A | N/A |
| 6/30/2014 | 535 | 18 | N/A | 87 | N/A |
| 3/31/2014 | 552 | 17 | N/A | N/A | N/A |
| 12/31/2013 | 557 | 15 | N/A | 109 | N/A |
| 9/30/2013 | 550 | 14 | N/A | N/A | N/A |
| 6/30/2013 | 547 | 16 | N/A | 62 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TUB's forecast earnings growth (23.3% per year) is above the savings rate (1.4%).
Earnings vs Market: TUB's earnings (23.3% per year) are forecast to grow faster than the Spanish market (9.9% per year).
High Growth Earnings: TUB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: TUB's revenue (8.5% per year) is forecast to grow faster than the Spanish market (4% per year).
High Growth Revenue: TUB's revenue (8.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TUB's Return on Equity is forecast to be low in 3 years time (19.2%).